Exact Mass: 637.23117

Exact Mass Matches: 637.23117

Found 33 metabolites which its exact mass value is equals to given mass value 637.23117, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

{4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-phosphono-phenoxy}-acetic acid

2-[4-(2-{[1-({[1,1-biphenyl]-4-yl}methyl)-2-oxoazepan-3-yl]-C-hydroxycarbonimidoyl}-2-[(1-hydroxyethylidene)amino]ethyl)-2-phosphonophenoxy]acetate

C32H36N3O9P (637.2189056)

18-(p-Iodophenyl)octadecyl phosphocholine

18-(4-Iodophenyl)octadecyl 2-(trimethylazaniumyl)ethyl phosphoric acid

C29H53INO4P (637.2756777999999)

6-O-alpha-D-Xylopyranosylalangiside

(-)-6-O-alpha-D-Xylopyranosylalangiside

C30H39NO14 (637.2370434)

Acetylmaymyrsine

[3R-(3alpha,5beta,5aalpha,6alpha,7alpha,9alpha,9aalpha,10R*)]-6,10-bis(Acetyloxy)-5a-[(acetyloxy)methyl]-7-(benzoyloxy)octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-5-yl ester 3-pyridinecarboxylic acid

C34H39NO11 (637.2522984)

C34H39NO11

C34H39NO11 (637.2522984)

Angulatueoid A

C34H39NO11 (637.2522984)

1beta-cis-cinnamoyl-4alpha,5alpha-dihydroxy-7beta,11-diacetoxy-8beta-nicotinoyldihydroagarofuran|triptersinine D

C34H39NO11 (637.2522984)

Glu Val Phe Asp Glu

C28H39N5O12 (637.2595094000001)

Morphine 3,6-diglucuronide

C29H35NO15 (637.2006600000001)

EVFDE

Glu-Val-Phe-Asp-Glu

C28H39N5O12 (637.2595094000001)

[(2S,4R,6S)-5-(1,3-dioxoisoindol-2-yl)-6-(4-methoxyphenoxy)-4-phenylmethoxy-2-(phenylmethoxymethyl)oxan-3-yl] acetate

C37H35NO9 (637.23117)

2-methyl-4-[[4-[[4-[(3-tolyl)amino]phenyl][4-[(3-tolylimino]-2,5-cyclohexadien-1-ylidene]methyl]phenyl]amino]benzenesulphonic acid

C40H35N3O3S (637.2399)

Apramycin Sulphate Soluble

C21H43N5O15S (637.2476248)

Apramycin sulfate

C21H43N5O15S (637.2476248)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Apramycin sulfate is an aminoglycoside antibiotic produced by Streptomyces murica and used in veterinary medicine.

Luminate

C22H39N9O11S (637.2489624)

C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C2144 - Endothelial-Specific Integrin/Survival Signaling Inhibitor

Ethanaminium, 2-((hydroxy((18-(4-(iodo-131I)phenyl)octadecyl)oxy)phosphinyl)oxy)-N,N,N-trimethyl-, inner salt

C29H53INO4P (637.2756777999999)

C1446 - Radiopharmaceutical Compound > C129819 - Antineoplastic Radiopharmaceutical Agent C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate C274 - Antineoplastic Agent

18-(p-Iodophenyl)octadecyl phosphocholine

C29H53INO4P (637.2756777999999)

{4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-phosphono-phenoxy}-acetic acid

C32H36N3O9P (637.2189056)

N-feruloyl tyramine 4,4-O-beta-D-diglucoside

C30H39NO14 (637.2370434)

N-caffeoyl O-methyltyramine-4,5-O-beta-D-diglucoside

C30H39NO14 (637.2370434)

2-[4-[2-Acetamido-3-oxo-3-[[2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]propyl]-2-phosphonophenoxy]acetic acid

C32H36N3O9P (637.2189056)

ST 23:5;O8;HexNAc

C31H43NO13 (637.2734268)

Akt1-IN-1

C31H32FN5O5S2 (637.1828794)

Akt1-IN-1 (compound 5b) is a potent and selective Akt1 inhibitor with an IC50 value of 18.79 nM in MIA Paca-2 cells. Akt1-IN-1 does not exhibit obvious teratogenicity, hepatotoxicity and cardiotoxicity (No Observed Adverse Effect Level > 100 μM). Akt1-IN-1 can be used for researching anticancer[1].

(3s,4s,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

(3s,4s,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C30H39NO14 (637.2370434)

[4,5,8-tris(acetyloxy)-7-(benzoyloxy)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-6-yl]methyl pyridine-2-carboxylate

C34H39NO11 (637.2522984)

(3s,4r,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

(3s,4r,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C30H39NO14 (637.2370434)

(1s,2r,4s,5r,6r,7s,9r,12r)-5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-4-(benzoyloxy)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate

C34H39NO11 (637.2522984)

5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-4-(benzoyloxy)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate

C34H39NO11 (637.2522984)

[(1s,2r,4s,5r,6s,7s,8s,9r)-4,5,8-tris(acetyloxy)-7-(benzoyloxy)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-6-yl]methyl pyridine-2-carboxylate

C34H39NO11 (637.2522984)

2-(1-carboxy-n-{4-[(2s)-2-(carboxyamino)-2-({4-[3-hydroxy-2-(methoxycarbonyl)phenoxy]butyl}-c-hydroxycarbonimidoyl)ethyl]phenyl}formamido)benzoic acid

C31H31N3O12 (637.1907646)

(1s,2s,4r,5r,6r,7r,9r,12s)-5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-4-(benzoyloxy)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate

C34H39NO11 (637.2522984)

[(1s,2r,4s,5r,6s,7s,8s,9s)-4,5,8-tris(acetyloxy)-7-(benzoyloxy)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-6-yl]methyl pyridine-2-carboxylate

C34H39NO11 (637.2522984)

4-ethenyl-7-hydroxy-8-methoxy-3-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C30H39NO14 (637.2370434)